Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Director, Stakeholder Engagement Strategy & Operations to lead the global strategy, planning, and execution of advisory boards across the U.S., EU, and APAC. The role will also contribute to global congress planning, ensuring seamless integration of advisory boards with congress objectives and broader Medical Affairs priorities.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines